Pages that link to "Q5043714"
Jump to navigation
Jump to search
The following pages link to Carmine Zoccali (Q5043714):
Displaying 50 items.
- Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease (Q24617193) (← links)
- Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice (Q26767011) (← links)
- Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review (Q26799639) (← links)
- Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP) (Q27015990) (← links)
- How to deal with continuous and dichotomic outcomes in epidemiological research: linear and logistic regression analyses. (Q27691313) (← links)
- Reducing the costs of chronic kidney disease while delivering quality health care: a call to action (Q30234324) (← links)
- The systemic nature of CKD. (Q30234695) (← links)
- Obesity and Kidney Disease: Hidden Consequences of the Epidemic (Q30235506) (← links)
- Insulin resistance in chronic kidney disease: a systematic review (Q30244271) (← links)
- Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project (Q30245079) (← links)
- Multiple imputation: dealing with missing data (Q30638883) (← links)
- The analysis of survival data in nephrology: basic concepts and methods of Cox regression (Q31161205) (← links)
- The analysis of survival data: the Kaplan-Meier method (Q31161208) (← links)
- The heart rate response pattern to dialysis hypotension in haemodialysis patients. (Q33175070) (← links)
- An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. (Q33509778) (← links)
- The relationship between hemoglobin levels and endothelial functions in diabetes mellitus (Q33571310) (← links)
- Association of a polymorphism in a gene encoding a urate transporter with CKD progression (Q33715840) (← links)
- Chronic kidney disease and end-stage renal disease-a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe'. (Q33816875) (← links)
- When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study (Q34183375) (← links)
- Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. (Q34254721) (← links)
- Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study (Q34435887) (← links)
- Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD (Q34455424) (← links)
- Nocturnal hypoxemia: a neglected cardiovascular risk factor in end-stage renal disease? (Q34502035) (← links)
- Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria (Q34504490) (← links)
- Cultural adaptation and validation of the "Kidney Disease and Quality of Life--Short Form (KDQOL-SF™) version 1.3" questionnaire in Egypt (Q34511657) (← links)
- The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients (Q34615287) (← links)
- Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension. (Q34621043) (← links)
- Endogenous ouabain and cardiomyopathy in dialysis patients (Q34723285) (← links)
- Atherosclerosis in dialysis patients: does Chlamydia pneumoniae infection contribute to cardiovascular damage? (Q34766537) (← links)
- Hypertension as a cardiovascular risk factor in end-stage renal failure (Q34824991) (← links)
- Joint effect of insulin signaling genes on all-cause mortality (Q34954938) (← links)
- Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patients (Q34984003) (← links)
- ACE inhibition is renoprotective among obese patients with proteinuria (Q35012428) (← links)
- Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. (Q35017133) (← links)
- Estimated glomerular filtration rate, all-cause mortality and cardiovascular diseases incidence in a low risk population: the MATISS study. (Q35023602) (← links)
- Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD. (Q35051231) (← links)
- Inflammation and atherosclerosis in end-stage renal disease (Q35059398) (← links)
- Adipose tissue as a source of inflammatory cytokines in health and disease: Focus on end-stage renal disease (Q35106737) (← links)
- Traditional and emerging cardiovascular risk factors in end-stage renal disease (Q35129899) (← links)
- A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation (Q35144464) (← links)
- Oxidative stress in end-stage renal disease: an emerging threat to patient outcome (Q35155017) (← links)
- The importance of diabetic nephropathy in current nephrological practice (Q35205743) (← links)
- Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD. (Q35228536) (← links)
- The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP) (Q35573682) (← links)
- Promoting scientific collaboration and education in cardiovascular-renal medicine: EURECAM: An ERA-EDTA-based working group (Q35573867) (← links)
- ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease (Q35603923) (← links)
- Novel cardiovascular risk factors in end-stage renal disease (Q35611140) (← links)
- Achievement of target blood pressure levels in chronic kidney disease: a salty question? (Q35757830) (← links)
- Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition (Q35758311) (← links)
- Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study (Q35784920) (← links)